Jazz Pharmaceuticals plc — Director's Dealing 2018

Aug 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-08-10

Reporting Person: Treacy Paul (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-10	Ordinary Shares	S	1309	$176.6107	Disposed	17458	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F2: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.61 to $177.061. The price reported reflects the weighted
average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F3: Includes 126 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2018.